heidi hamm

From left, Sheila Collins, PhD, Ryan Ceddia, PhD, and Heidi Hamm, PhD, and their colleagues have identified a potential new approach to reducing the global impact of obesity and diabetes. (photo by Erin O. Smith)
September 6, 2023

Releasing a brake that drives obesity and diabetes

Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.

July 2, 2019

Former Pharmacology chair Hardman remembered as gifted scientist, educator, mentor

Joel Hardman, PhD, an internationally recognized scientist and educator who chaired the Department of Pharmacology at Vanderbilt University School of Medicine from 1975 to 1990, died June 30, 2019 in Hoosick Falls, New York, after a lengthy illness. He was 85.

March 7, 2019

Vanderbilt scientists report new modeling of brain signaling

The release of neurotransmitters and hormones in the body is tightly controlled by complex protein machinery embedded in cell membranes.

November 23, 2016

Reducing antidepressants’ side effects

Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.

January 15, 2015

VUMC investigators honored by ASPET

Vanderbilt’s Heidi Hamm, Ph.D., and L. Jackson Roberts II, M.D., have been lauded by the American Society for Pharmacology and Experimental Therapeutics (ASPET).

June 19, 2014

Hamm’s lasting impact commended at Flexner Discovery Lecture